Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 / ...

The approval comes amid regulatory upheaval under HHS head Robert F. Kennedy Jr., who has pushed for changes around mRNA ...

Moderna’s shares were up nearly 3% at the time of writing. The vaccine was previously available for pediatric populations ...

The life-saving impact of global vaccine stockpiles to address outbreaks of vaccine-preventable diseases has been ...

Los Angeles, Orange, Riverside and San Bernardino counties have reported eight cases so far this year compared to 10 total in ...

China’s first domestically made nine-valent HPV vaccine, a direct competitor to Merck’s Gardasil 9, is being priced at 499 ...

The United States has reported more cases in 2025 than in any year since 1992. The majority of this year's cases stem from ...

Secretary Kennedy’s latest maneuver seeks to expand vaccine injury lawsuits, echoing a precarious time in US history when ...

Measles cases in the United States have reached their highest level in 25 years, with more than 1,270 confirmed cases this year.

House Democrats on the Oversight Committee sent a letter to the CDC chief of staff on Thursday, demanding answers over recent moves related to the ACIP.

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...